About Us
InCHIP serves as a nexus for investigators at the University of Connecticut and other institutions to stimulate collaborative partnerships for the development of major research initiatives in health behavior change.
InCHIP has created a multidisciplinary network of more than 480 affiliate investigators with expertise in health behavior change and intervention. This network of affiliates spans several University of Connecticut campuses, representing nearly all Schools and Colleges within the UConn system, and it also draws from more than 60 other research institutions.
The network enables InCHIP to assemble teams of investigators able to respond within short time frames to large-scale research funding opportunities as they arise.
Upcoming InCHIP Events
-
Dec
5
InCHIP Lecture Series: Technology-based HIV Prevention and Treatment Interventions for Adolescents and Young Adults 12:30pm
InCHIP Lecture Series: Technology-based HIV Prevention and Treatment Interventions for Adolescents and Young Adults
Thursday, December 5th, 2024
12:30 PM - 01:30 PM
Virtual
In Recognition of World AIDS Day
Lisa B. Hightow-Weidman, MD, MPH
Topic: Technology-based HIV Prevention and Treatment Interventions for Adolescents and Young Adults
December 5, 2024 | 12:30 PM | WebExLisa B. Hightow-Weidman, MD, MPH is a Distinguished and Endowed McKenzie Professor in the College of Nursing at the Florida State University (FSU). She is the founding director of the Institute on Digital Health and Innovation at FSU.
Dr. Hightow-Weidman is an expert in the development, implementation and evaluation of digital health interventions (DHIs) to address the HIV Care Continuum for adolescents and young adults, particularly among sexual and gender minority populations. Her research interests include technology-based HIV prevention and treatment interventions for adolescents and emerging adults, specifically interventions that incorporate game-based elements, self-monitoring and tracking and provision of social support to increase engagement and impact health behavior. She has developed technology-based interventions that aim to increase uptake and adherence to biomedical prevention and treatment, to increase HIV diagnosis, linkage and retention in care and to ameliorate stigma and increase resilience. She has published nearly 200 peer-reviewed articles on these topics and has a proven track record of successful funding from the National Institutes of Health, HIV/AIDS Bureau and the Centers for Disease Control and Prevention.Contact Information:
More -
Dec
12
“Moving Beyond Implications: Research into Policy” Conference 11:30am
“Moving Beyond Implications: Research into Policy” Conference
Thursday, December 12th, 2024
11:30 AM - 06:00 PM
Legislative Office Building, 300 Capitol Ave, Hartford, CT 06106
CT SSN is excited to partner with Representative Jaime Foster (D-57 (Ellington, East Windsor, and Vernon)), Representative Dominique Johnson (D-143 (Norwalk and Westport)), and UConn’s InCHIP to host the second “Moving Beyond Implications: Research into Policy” (Moving Beyond) conference. The conference will bring together academics, legislators, and other policymakers in advance of the 2025 Connecticut legislative session.When: Thursday, December 12, 2024 | 11:30am lunch | 12pm-6pm conference programming
Where: Legislative Office Building, 300 Capitol Ave, Hartford, CT 06106 -
Feb
27
InCHIP Lecture Series: Cardiovascular Disease and Depression 12:30pm
InCHIP Lecture Series: Cardiovascular Disease and Depression
Thursday, February 27th, 2025
12:30 PM - 01:30 PM
Virtual
In Recognition of Heart Health Month
Kenneth E. Freedland, Ph.D., Washington University School of Medicine in St. Louis
Topic: Cardiovascular Disease and Depression
February 27, 2025 | 12:30 PM | WebExDr. Freedland is a Professor of Psychiatry and Psychology at Washington University School of Medicine in St. Louis. Most of his research has focused on depression in patients with heart failure or coronary heart disease. He has also conducted studies of other psychiatric comorbidities, behavioral problems such as poor self-care, and social determinants of health in patients with heart failure. He has been the principal investigator or a co-investigator on both single-site and multicenter trials of interventions for depression in cardiac patients and has served on clinical trial review committees for the National Heart, Lung, and Blood Institute (NHLBI) and the Patient-Centered Outcomes Research Institute (PCORI). He also has expertise in behavioral trial methodology. Dr. Freedland is the founder of the Society of Behavioral Medicine’s Cardiovascular Disease Special Interest Group and of the Behavioral Medicine Research Council, and a fellow of multiple organizations including the Academy of Behavioral Medicine Research. He was the Program Director of the annual NIH Summer Institute on Randomized Behavioral Clinical Trials from 2020 to 2024. He has been a member of the Summer Institute faculty since 2007 and the faculty of the NIH-funded ORBIT Institute on Developing Behavioral Treatments to Improve Health since 2022. He has also served as an Associate Editor of Psychosomatic Medicine and Editor-in-Chief of Health Psychology.
Get Started
InCHIP offers a large variety of services to its membership. To see what services you qualify for, click the "Get Started" button.
Get Started!
Contact Us
Phone: | 860-486-5917 |
---|---|
E-mail: | chip.services@chip.uconn.edu |
Address: | 2006 Hillside Rd Storrs, CT 06269 |
More: | http://www.inchip.uconn.edu |